Cell biology of osteochondromas: Bone morphogenic protein signalling and heparan sulphates

Araceli Cuellar, A Hari Reddi

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Frequent benign outgrowths from bone known as osteochondromas, exhibiting typical endochondral ossification, are reported from single to multiple lesions. Characterised by a high incidence of osteochondromas and skeletal deformities, multiple hereditary exostoses (MHE) is the most common inherited musculoskeletal condition. While factors for severity remain unknown, mutations in exostosin 1 and exostosin 2 genes, encoding glycosyltransferases involved in the biosynthesis of ubiquitously expressed heparan sulphate (HS) chains, are associated with MHE. HS-binding bone morphogenetic proteins (BMPs) are multifunctional proteins involved in the morphogenesis of bone and cartilage. HS and HS proteoglycans are involved in BMP-mediated morphogenesis by regulating their gradient formation and activity. Mutations in exostosin genes disturb HS biosynthesis, subsequently affecting its functional role in the regulation of signalling pathways. As BMPs are the primordial morphogens for bone development, we propose the hypothesis that BMP signalling may be critical in osteochondromas. For this reason, the outcomes of exostosin mutations on HS biosynthesis and interactions within osteochondromas and MHE are reviewed. Since BMPs are HS binding proteins, the interactions of HS with the BMP signalling pathway are discussed. The impact of mouse models in the quest to better understand the cell biology of osteochondromas is discussed. Several challenges and questions still remain and further investigations are needed to explore new approaches for better understanding of the pathogenesis of osteochondromas.

Original languageEnglish (US)
Pages (from-to)1591-1596
Number of pages6
JournalInternational Orthopaedics
Volume37
Issue number8
DOIs
StatePublished - Aug 2013

Fingerprint

Osteochondroma
Heparitin Sulfate
Bone Morphogenetic Proteins
Cell Biology
Bone and Bones
Multiple Hereditary Exostoses
Proteins
Morphogenesis
Mutation
Carrier Proteins
Heparan Sulfate Proteoglycans
Glycosyltransferases
Bone Development
Osteogenesis
Genes
Cartilage
Incidence

ASJC Scopus subject areas

  • Orthopedics and Sports Medicine

Cite this

Cell biology of osteochondromas : Bone morphogenic protein signalling and heparan sulphates. / Cuellar, Araceli; Reddi, A Hari.

In: International Orthopaedics, Vol. 37, No. 8, 08.2013, p. 1591-1596.

Research output: Contribution to journalArticle

@article{c13b894e4b684d75b383faa74df82f8f,
title = "Cell biology of osteochondromas: Bone morphogenic protein signalling and heparan sulphates",
abstract = "Frequent benign outgrowths from bone known as osteochondromas, exhibiting typical endochondral ossification, are reported from single to multiple lesions. Characterised by a high incidence of osteochondromas and skeletal deformities, multiple hereditary exostoses (MHE) is the most common inherited musculoskeletal condition. While factors for severity remain unknown, mutations in exostosin 1 and exostosin 2 genes, encoding glycosyltransferases involved in the biosynthesis of ubiquitously expressed heparan sulphate (HS) chains, are associated with MHE. HS-binding bone morphogenetic proteins (BMPs) are multifunctional proteins involved in the morphogenesis of bone and cartilage. HS and HS proteoglycans are involved in BMP-mediated morphogenesis by regulating their gradient formation and activity. Mutations in exostosin genes disturb HS biosynthesis, subsequently affecting its functional role in the regulation of signalling pathways. As BMPs are the primordial morphogens for bone development, we propose the hypothesis that BMP signalling may be critical in osteochondromas. For this reason, the outcomes of exostosin mutations on HS biosynthesis and interactions within osteochondromas and MHE are reviewed. Since BMPs are HS binding proteins, the interactions of HS with the BMP signalling pathway are discussed. The impact of mouse models in the quest to better understand the cell biology of osteochondromas is discussed. Several challenges and questions still remain and further investigations are needed to explore new approaches for better understanding of the pathogenesis of osteochondromas.",
author = "Araceli Cuellar and Reddi, {A Hari}",
year = "2013",
month = "8",
doi = "10.1007/s00264-013-1906-5",
language = "English (US)",
volume = "37",
pages = "1591--1596",
journal = "International Orthopaedics",
issn = "0341-2695",
publisher = "Springer Verlag",
number = "8",

}

TY - JOUR

T1 - Cell biology of osteochondromas

T2 - Bone morphogenic protein signalling and heparan sulphates

AU - Cuellar, Araceli

AU - Reddi, A Hari

PY - 2013/8

Y1 - 2013/8

N2 - Frequent benign outgrowths from bone known as osteochondromas, exhibiting typical endochondral ossification, are reported from single to multiple lesions. Characterised by a high incidence of osteochondromas and skeletal deformities, multiple hereditary exostoses (MHE) is the most common inherited musculoskeletal condition. While factors for severity remain unknown, mutations in exostosin 1 and exostosin 2 genes, encoding glycosyltransferases involved in the biosynthesis of ubiquitously expressed heparan sulphate (HS) chains, are associated with MHE. HS-binding bone morphogenetic proteins (BMPs) are multifunctional proteins involved in the morphogenesis of bone and cartilage. HS and HS proteoglycans are involved in BMP-mediated morphogenesis by regulating their gradient formation and activity. Mutations in exostosin genes disturb HS biosynthesis, subsequently affecting its functional role in the regulation of signalling pathways. As BMPs are the primordial morphogens for bone development, we propose the hypothesis that BMP signalling may be critical in osteochondromas. For this reason, the outcomes of exostosin mutations on HS biosynthesis and interactions within osteochondromas and MHE are reviewed. Since BMPs are HS binding proteins, the interactions of HS with the BMP signalling pathway are discussed. The impact of mouse models in the quest to better understand the cell biology of osteochondromas is discussed. Several challenges and questions still remain and further investigations are needed to explore new approaches for better understanding of the pathogenesis of osteochondromas.

AB - Frequent benign outgrowths from bone known as osteochondromas, exhibiting typical endochondral ossification, are reported from single to multiple lesions. Characterised by a high incidence of osteochondromas and skeletal deformities, multiple hereditary exostoses (MHE) is the most common inherited musculoskeletal condition. While factors for severity remain unknown, mutations in exostosin 1 and exostosin 2 genes, encoding glycosyltransferases involved in the biosynthesis of ubiquitously expressed heparan sulphate (HS) chains, are associated with MHE. HS-binding bone morphogenetic proteins (BMPs) are multifunctional proteins involved in the morphogenesis of bone and cartilage. HS and HS proteoglycans are involved in BMP-mediated morphogenesis by regulating their gradient formation and activity. Mutations in exostosin genes disturb HS biosynthesis, subsequently affecting its functional role in the regulation of signalling pathways. As BMPs are the primordial morphogens for bone development, we propose the hypothesis that BMP signalling may be critical in osteochondromas. For this reason, the outcomes of exostosin mutations on HS biosynthesis and interactions within osteochondromas and MHE are reviewed. Since BMPs are HS binding proteins, the interactions of HS with the BMP signalling pathway are discussed. The impact of mouse models in the quest to better understand the cell biology of osteochondromas is discussed. Several challenges and questions still remain and further investigations are needed to explore new approaches for better understanding of the pathogenesis of osteochondromas.

UR - http://www.scopus.com/inward/record.url?scp=84881240110&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84881240110&partnerID=8YFLogxK

U2 - 10.1007/s00264-013-1906-5

DO - 10.1007/s00264-013-1906-5

M3 - Article

C2 - 23771188

AN - SCOPUS:84881240110

VL - 37

SP - 1591

EP - 1596

JO - International Orthopaedics

JF - International Orthopaedics

SN - 0341-2695

IS - 8

ER -